Product Information
LEVOCETIRIZINE 5 MG TABLET is a generic product labeled by Westminster Pharmaceuticals LLC, priced at $0.0534 per EA under NDC 69367023809. Its NADAC has been published 342 times since Dec 11, 2019.
Strength
5 mg/1
Manufacturer
Westminster Pharmaceuticals LLCNDC
69367023809
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LEVOCETIRIZINE DIHYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA203646On Market Since
9/19/2019
Pharmacological Classes
Price Statistics
The NADAC for LEVOCETIRIZINE 5 MG TABLET has been published 342 times since Dec 11, 2019, and over the history we have for it it has declined 38.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0534 per EA |
|---|---|
| All-time high | $0.0891 (Jan 15, 2020) |
| All-time low | $0.0534 (Jun 17, 2026) |
| 52-week high | $0.0617 |
| 52-week low | $0.0534 |
| Median price | $0.0732 |
| Average price | $0.0713 |
| Largest weekly change | -17.1% (Apr 17, 2024) |
| Weeks tracked | 342 |
| Tracking since | Dec 11, 2019 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LEVOCETIRIZINE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LEVOCETIRIZINE 5 MG TABLET, manufactured by Westminster Pharmaceuticals LLC, is $0.0534 per EA (NDC 69367023809), effective Jun 24, 2026.
How has the price of LEVOCETIRIZINE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for LEVOCETIRIZINE 5 MG TABLET has declined 38.2%. It has been tracked across 342 weekly CMS publications since Dec 11, 2019.
What are the highest and lowest recorded NADAC prices for LEVOCETIRIZINE 5 MG TABLET?
Since Dec 11, 2019, the NADAC for LEVOCETIRIZINE 5 MG TABLET has ranged from a low of $0.0534 (Jun 17, 2026) to a high of $0.0891 (Jan 15, 2020), with a median of $0.0732 per EA.
Are there cheaper alternatives to LEVOCETIRIZINE 5 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as LEVOCETIRIZINE 5 MG TABLET, but none are currently priced below it.
Who manufactures LEVOCETIRIZINE 5 MG TABLET?
LEVOCETIRIZINE 5 MG TABLET (NDC 69367023809) is labeled by Westminster Pharmaceuticals LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification